NCT05934331 2025-09-12
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
LaNova Medicines Limited
Phase 2 Recruiting
LaNova Medicines Limited
Zhejiang University
Innovative Cellular Therapeutics Co., Ltd.
M.D. Anderson Cancer Center